氧化半氨酸的后翻译性修改驱动了底层神经退行症和肌缩性侧面硬化症的Redox代码
Anna Percio1,2, Michela Cicchinelli1,2, Domiziana Masci1
1Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Antioxidants (Basel, Switzerland)
|August 29, 2024
概括
降解氧失调通过改变囊后翻译修饰 (PTMs) 对神经退行产生影响. 这些氨酸PTMs影响蛋白质的功能和聚合,特别是在诸如肌缩性侧面硬化症 (ALS) 等疾病中.
科学领域:
- 细胞还氧化生物学 细胞还氧化生物学
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 氧化剂和抗氧化剂的不平衡,即氧失调,与神经退行性疾病有关.
- 细胞复原体依赖于对氨酸敏感的蛋白质来实现恒常和信号传递.
- 半氨酸残留物容易发生影响蛋白质功能的氧化后翻译性修饰 (PTMs).
研究的目的:
- 探索囊PTMs在细胞氧化还原环境中的作用.
- 阐明氨酸PTMs对蛋白质水平的神经退行变化的影响.
- 为了强调氧化还原失调和肌缩性侧面硬化症 (ALS) 之间的联系.
主要方法:
- 审查现有的关于氧化还原生物学,氨酸PTM和神经退行现象的文献.
- 对氧化应激对囊敏感蛋白质的影响分析.
- 研究神经退行性疾病中的特定的囊敏感蛋白和调节网络,重点关注ALS.
主要成果:
- 半氨酸PTM对于生理和病理状态中的氧化还原信号至关重要.
- 这些修改显著影响蛋白质错误折叠和聚合,这是神经退行症的标志.
- 氧化还原失调是神经退行性疾病的明显标志,特别是ALS.
结论:
- 氨酸PTM是神经退行性疾病发病的关键媒介.
- 了解这些修改可以了解疾病机制和潜在的治疗点.
- 在研究氧化还原失调和神经退行之间的复杂关系方面,ALS是重要的模型.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome
818
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
818


